Nursing: Blood Transfusion Administration

Blood transfusions are a cornerstone of modern medical care, capable of restoring volume, improving oxygenation, and correcting coagulopathies. However, they are not without risk; even a single error can lead to severe patient harm or death. Your role as a nurse in meticulously verifying, administering, and monitoring these products is therefore one of the most critical safeguards in patient safety.

The Foundation of Safety: Blood Group Compatibility and Pre-Transfusion Checks

Every safe transfusion begins with a thorough understanding of blood group compatibility. The ABO system classifies blood based on the presence or absence of A and B antigens on red blood cells, while the Rh factor denotes the presence (Rh-positive) or absence (Rh-negative) of the D antigen. Compatibility is non-negotiable: for example, a patient with Type A blood can only receive Type A or Type O blood, and an Rh-negative patient should generally receive Rh-negative blood to prevent sensitization. This knowledge underpins the laboratory processes you must verify before any blood product leaves the blood bank.

These processes are type and crossmatch verification. "Type" refers to determining the patient's ABO and Rh status, while "crossmatch" is a final compatibility test between the patient's serum and the donor red cells. As the nurse, you are the last line of defense. You must verify that the blood product's ABO group, Rh type, unit number, and expiration date exactly match the information on the patient's blood bank slip and physician's order. Any discrepancy, no matter how small, means you must not administer the product and must immediately contact the blood bank. This rigorous verification prevents the most catastrophic reaction: an acute hemolytic transfusion reaction.

The Bedside Safeguard: Positive Patient Identification and Preparation

With compatible blood verified, your focus shifts to the bedside. Patient identification is the single most important step you will perform. You must use two unique patient identifiers, such as name and medical record number—never the room or bed number. This identification must be checked against the wristband and the blood product label with a second qualified nurse or per institutional policy. Simultaneously, you conduct a pre-transfusion assessment, establishing baseline vital signs and ensuring informed consent is documented. You also assess vascular access, typically using a large-bore (18- to 20-gauge) intravenous catheter, and confirm that only normal saline (0.9% NaCl) is connected to the same line, as other solutions can cause hemolysis.

Consider this vignette: You are preparing to transfuse Mr. Jones, a 65-year-old with gastrointestinal bleeding. You call a colleague to witness the identification process. Together, you ask Mr. Jones to state his full name and date of birth, which you match to his wristband and the blood requisition form. You then compare every detail on the blood bag to the paperwork. Only after this meticulous, two-person check do you proceed. This process, though seemingly repetitive, is designed to catch human error and is your primary tool for preventing a wrong-blood event.

The Vigilant Infusion: Administration and Monitoring Protocols

Once identification is confirmed, you begin the infusion monitoring phase. You will start the transfusion slowly, typically at 2 mL/min for the first 15 minutes, as most severe reactions manifest early. You must remain with the patient for this initial period. Vital sign monitoring protocols are strict: you will assess temperature, pulse, blood pressure, and respiratory rate before the transfusion, 15 minutes after initiation, and then at least every hour until one hour post-transfusion, or more frequently per protocol. This vigilance allows for early detection of adverse signs.

The transfusion should be completed within four hours to minimize bacterial growth risk, using an infusion pump designed for blood products. Throughout, you monitor for subjective complaints like chills, itching, or pain, and objective signs such as rash, respiratory distress, or oozing from IV sites. Documenting every step—start time, vital signs, product details, patient tolerance, and completion time—creates a legal and clinical record. Your constant surveillance transforms the transfusion from a simple IV medication into a dynamic, high-alert nursing intervention.

When Things Go Wrong: Recognizing and Responding to Transfusion Reactions

Despite all precautions, reactions can occur. You must be able to rapidly identify transfusion reaction types and initiate immediate nursing interventions. The most urgent is an acute hemolytic reaction, caused by ABO incompatibility, where the patient's antibodies destroy donor red cells. Signs include fever, chills, low back pain, hypotension, tachycardia, hemoglobinuria (dark urine), and a sense of impending doom. An allergic response, often to plasma proteins, typically presents with hives, itching, and localized edema, while a severe anaphylactic reaction involves bronchospasm and hypotension.

Other types include febrile non-hemolytic reactions (fever, chills) and transfusion-related acute lung injury (TRALI), characterized by sudden hypoxemia and pulmonary edema. Your immediate action for any suspected reaction is universal: stop the transfusion immediately. Keep the IV line open with normal saline to maintain vascular access. Notify the physician and the blood bank stat. Then, disconnect the blood tubing and replace it with new tubing containing normal saline to prevent further infusion of the reaction-causing product. Send the remaining blood product, tubing, and a freshly drawn blood sample from the opposite arm to the lab for analysis. Your swift, prioritized response limits harm and guides definitive treatment.

Common Pitfalls

1. Inadequate Patient Identification: Relying on a room number or assuming patient identity without a dual-check process. Correction: Always use two unique identifiers and involve a second nurse for the final verification at the bedside, comparing wristband to paperwork and blood product.
2. Lax Monitoring Practices: Assuming reactions are rare and leaving the patient unattended early in the transfusion or extending vital sign intervals. Correction: Adhere strictly to institutional monitoring protocols (e.g., staying for the first 15 minutes, taking vitals at 15 minutes). Your presence is a therapeutic intervention.
3. Delaying the Stop: Hesitating to stop the transfusion when subtle signs like mild itching or a slight temperature rise occur, hoping they will pass. Correction: Any new symptom or sign during a transfusion is a reaction until proven otherwise. Stop the infusion first, then assess. A delayed stop can turn a mild reaction into a severe one.
4. Confusing Reaction Types: Misinterpreting the classic symptoms. For instance, attributing low back pain and dark urine to a pre-existing condition rather than recognizing it as hemolytic reaction. Correction: Know the differential signs. Hemolytic reactions often have pain and hemodynamic changes; allergic reactions feature urticaria; febrile reactions are typically fever and chills without hypotension.

Summary

• Verification is Paramount: Meticulous type and crossmatch verification and two-person patient identification using unique identifiers are the absolute foundations of transfusion safety, preventing ABO-incompatible transfusions.
• Monitoring is Non-Negotiable: Adhere strictly to vital sign monitoring protocols and stay with the patient during the initial infusion to enable early detection of adverse events.
• Know the Reactions: Distinguish between transfusion reaction types such as acute hemolytic (fever, pain, hypotension), allergic (hives, itching), and febrile responses to assess severity accurately.
• Act Immediately on Suspicion: Your core immediate nursing intervention for any suspected reaction is to stop the transfusion, keep the IV open with saline, notify the physician and blood bank, and send the product for analysis.
• Document Everything: Complete and timely documentation of every step from verification to monitoring provides a critical legal record and ensures continuity of care.